Company Directory > CDMO > Midas Care Pharmaceuticals
Midas Care Pharmaceuticals is one of India's leading pharmaceutical and consumer healthcare companies, recognized as a pioneer in aerosol technology. Founded in 1986, the company specializes in the development and manufacturing of a wide range of healthcare, personal care, and home care products, with a strong emphasis on spray-based delivery systems. The company is well-known for its iconic household brands in India, including Relispray (pain relief), Spraymintt (mouth freshener), and Clean & Dry (intimate hygiene). Beyond its own brands, Midas Care operates as a significant CDMO (Contract Development and Manufacturing Organization), providing specialized aerosol manufacturing services to global pharmaceutical and FMCG giants.
CLASSIFICATION
Company Type:CDMO
Industry:Pharmaceuticals
Sub-Industry:Consumer Healthcare & CDMO
SIZE & FINANCIALS
Employees:501-1000
Revenue:$50M-$100M
Founded:1986
Ownership:private
Status:operating
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial
Modalities:Aerosols, Topical Sprays, Foams, Liquids
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Contract manufacturing partner for various Fortune 500 FMCG companies, Distribution partners in SE Asia and Middle East
COMPETITION
Position:Leader
Competitors:Cipla (Health), Reckitt Benckiser, Piramal Enterprises, Zydus Wellness, Haleon
LEADERSHIP
Key Executives:
Brij Bandhu Gupta - Founder & Chairman
Shivangi Gupta - Director
Scientific Founders:Brij Bandhu Gupta
Board Members:Brij Bandhu Gupta, Shivangi Gupta
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Midas Care Pharmaceuticals. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.